James A Gossage
Overview
Explore the profile of James A Gossage including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
281
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yan H, Zhu H, Cai Y, Xin D, Cai G, Zou B, et al.
J Thorac Dis
. 2024 Dec;
16(11):7787-7796.
PMID: 39678850
Background: The rare incidence of small cell carcinoma of the esophagus (SCCE) makes prospective studies difficult to conduct, the efficacy of existing standard treatment regimens for SCCE is therefore highly...
2.
Walker R, Barman S, Pucher P, Singh P, Whyte G, Moore J, et al.
Br J Surg
. 2024 Oct;
111(10).
PMID: 39446994
Background: Prehabilitation is safe, feasible and may improve a range of outcomes in patients with oesophago-gastric cancer (OGC). Recent studies have suggested the potential of prehabilitation to improve body composition,...
3.
Pucher P, Rahman S, Bhandari P, Blencowe N, Chidambaram S, Crosby T, et al.
Ann Surg
. 2024 Sep;
281(3):363-370.
PMID: 39219545
Objective: The aim of this study was to quantify lymph node metastasis (LNM) risk and outcomes following treatment of early esophago-gastric (EG) adenocarcinoma. Background: The standard of care for early...
4.
Farrow H, Pickering O, Gossage J, Pucher P
Eur J Surg Oncol
. 2023 Nov;
50(1):107271.
PMID: 37979459
Practice is variable in the inclusion or exclusion of the thoracic duct (TD) as part of the resected specimen and associated lymphadenectomy in radical esophagectomy for esophageal cancer. While some...
5.
Moore J, Green M, Santaolalla A, Deere H, Evans R, Elshafie M, et al.
J Clin Oncol
. 2023 Jul;
41(28):4522-4534.
PMID: 37499209
Purpose: There is limited evidence regarding the prognostic effects of pathologic lymph node (LN) regression after neoadjuvant chemotherapy for esophageal adenocarcinoma, and a definition of LN response is lacking. This...
6.
Casey P, Gossage J, Ford K, Huddy F, Owen K, Harvey A, et al.
Clin Nutr ESPEN
. 2023 Jun;
56:87-93.
PMID: 37344089
Background And Aims: Specialist nutritional support is important during treatment for oesophagogastric (OG) cancer yet current practice remains unstandardised across the UK. The National Oesophagogastric Nutrition Audit (NONA) aimed to...
7.
Pucher P, Park M, Cromwell D, Crosby T, Thomas B, Trudgill N, et al.
Br J Surg
. 2023 Mar;
110(6):701-709.
PMID: 36972221
Background: The National Oesophago-Gastric Cancer Audit (NOGCA) captures patient data from diagnosis to end of primary treatment for all patients with oesophagogastric (OG) cancer in England and Wales. This study...
8.
Moore J, Subesinghe M, Santaolalla A, Green M, Deere H, Van Hemelrijck M, et al.
Eur Radiol
. 2023 Mar;
33(5):3647-3659.
PMID: 36920518
Objectives: 2-deoxy-2[F]Fluoro-D-glucose (FDG) PET-CT has an emerging role in assessing response to neoadjuvant therapy in oesophageal cancer. This study evaluated FDG PET-CT in predicting pathological tumour response (pTR), pathological nodal...
9.
Kamarajah S, Evans R, Griffiths E, Gossage J, Pucher P
BJS Open
. 2022 Dec;
6(6).
PMID: 36477836
Background: The literature lacks robust evidence comparing definitive chemoradiotherapy (dCRT) with neoadjuvant chemoradiotherapy and surgery (nCRS) for oesophageal squamous cell carcinoma (ESCC). This study aimed to compare long-term survival of...
10.
Pucher P, Coombes A, Evans O, Taylor J, Moore J, White A, et al.
Support Care Cancer
. 2022 Mar;
30(6):5269-5275.
PMID: 35275293
Purpose: Long-lasting symptoms and reductions in quality of life are common after oesophago-gastric surgery. Post-operative follow-up has traditionally focussed on tumour recurrence and survival, but there is a growing need...